Bibliographic Citation
| - Baldacci Simon, Avrillon Virginie, Besse Benjamin, Mennecier Bertrand, Duruisseaux Michael, Mazières Julien, Descourt Renaud, Doubre Helene, Dubray-Longeras Pascale, Cadranel Jacques, Moro-Sibilot Denis, Ricordel Charles, Galland-Girodet Sigolene, Monnet Isabelle, Otto Josiane, Schneider Sophie, Missy Pascale, Morin Franck, Westeel Virginie, Girard Nicolas. Lorlatinib for advanced ALK and ROS1+non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort.. Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (15), ⟨10.1200/JCO.2020.38.15_suppl.9615⟩
- Baldacci Simon, Avrillon Virginie, Besse Benjamin, Cadranel Jacques, Ricordel Charles, Monnet Isabelle, Otto Josiane, Morin Franck, Westeel Virginie, Girard Nicolas. Lorlatinib for advanced ALK and ROS1+non-small cell lung cancer (NSCLC): Efficacy and treatment sequences in the IFCT-1803 LORLATU expanded access program (EAP) cohort.. Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (15), ⟨10.1200/JCO.2020.38.15_suppl.9615⟩
|